![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Nivalis Therapeutics, Inc. (MM) | NASDAQ:NVLS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.40 | 2.00 | 2.45 | 0 | 01:00:00 |
CUSIP No. 02083G100
|
Page 2 of 11 Pages
|
||||
1
|
NAME OF REPORTING PERSONS
OrbiMed Advisors LLC
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
☐
(b)
☐
|
||||
3
|
SEC USE ONLY
|
||||
4
|
SOURCE OF FUNDS (See Instructions)
AF
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
☐
|
|||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||||
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
7
|
SOLE VOTING POWER
0
|
|||
8
|
SHARED VOTING POWER
3,298,516
|
||||
9
|
SOLE DISPOSITIVE POWER
0
|
||||
10
|
SHARED DISPOSITIVE POWER
3,298,516
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,298,516
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
☐
|
|||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
23.76% *
|
||||
14
|
TYPE OF REPORTING PERSON (See Instructions)
IA
|
CUSIP No.
02083G100
|
Page 3 of 11 Pages
|
||||
1
|
NAME OF REPORTING PERSONS
OrbiMed Capital GP VI LLC
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
☐
(b)
☐
|
||||
3
|
SEC USE ONLY
|
||||
4
|
SOURCE OF FUNDS (See Instructions)
AF
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
☐
|
|||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||||
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
7
|
SOLE VOTING POWER
0
|
|||
8
|
SHARED VOTING POWER
3,298,516
|
||||
9
|
SOLE DISPOSITIVE POWER
0
|
||||
10
|
SHARED DISPOSITIVE POWER
3,298,516
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,298,516
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
☐
|
|||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
23.76%*
|
||||
14
|
TYPE OF REPORTING PERSON (See Instructions)
OO
|
CUSIP No.
02083G100
|
Page 4 of 11 Pages
|
||||
1
|
NAME OF REPORTING PERSONS
Samuel D. Isaly
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
☐
(b)
☐
|
||||
3
|
SEC USE ONLY
|
||||
4
|
SOURCE OF FUNDS (See Instructions)
AF
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
☐
|
|||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
||||
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
7
|
SOLE VOTING POWER
0
|
|||
8
|
SHARED VOTING POWER
3,298,516
|
||||
9
|
SOLE DISPOSITIVE POWER
0
|
||||
10
|
SHARED DISPOSITIVE POWER
3,298,516
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,298,516
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
☐
|
|||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
23.76%*
|
||||
14
|
TYPE OF REPORTING PERSON (See Instructions)
IN
|
Item 1.
|
Security and Issuer
|
Item 2. |
Identity and Background
|
Item 3. |
Source and Amount of Funds or Other Consideration
|
Item 4. |
Purpose of Transaction
|
Item 5. |
Interest in Securities of the Issuer
|
Item 6. |
Contracts, Arrangements, Understandings or Relationship with Respect to Securities of the Issuer
|
Item 7. |
Materials to Be Filed as Exhibits
|
Exhibit
|
Description
|
1.
|
Joint Filing Agreement among OrbiMed Advisors LLC, OrbiMed Capital GP VI LLC and Samuel D. Isaly.
|
2.
|
Form of Lock-Up Agreement.
|
OrbiMed Advisors LLC
|
||||
By:
|
/s/ Samuel D. Isaly
|
|||
Name:
|
Samuel D. Isaly
|
|||
Title:
|
Managing Member
|
OrbiMed Capital GP VI LLC
|
||||
By:
|
OrbiMed Advisors LLC
its Managing Member
|
|||
By:
|
/s/ Samuel D. Isaly
|
|||
Name:
|
Samuel D. Isaly
|
|||
Title:
|
Managing Member
|
|||
Samuel D. Isaly
|
||||
By:
|
/s/ Samuel D. Isaly
|
|||
Name:
|
Samuel D. Isaly
|
Name
|
Position with Reporting
Person |
Principal Occupation
|
Samuel D. Isaly
|
Managing Member
|
Managing Member
OrbiMed Advisors LLC |
Carl L. Gordon
|
Member
|
Member
OrbiMed Advisors LLC |
Sven H. Borho
German and Swedish Citizen |
Member
|
Member
OrbiMed Advisors LLC |
Jonathan T. Silverstein
|
Member
|
Member
OrbiMed Advisors LLC |
W. Carter Neild
|
Member
|
Member
OrbiMed Advisors LLC |
Geoffrey C. Hsu
|
Member
|
Member
OrbiMed Advisors LLC |
Evan D. Sotiriou
|
Chief Financial Officer
|
Chief Financial Officer
OrbiMed Advisors LLC |
Exhibit
|
Description
|
1.
|
Joint Filing Agreement among OrbiMed Advisors LLC, OrbiMed Capital GP VI LLC and Samuel D. Isaly.
|
2.
|
Form of Lock-Up Agreement.
|
1 Year NIVALIS THERAPEUTICS, INC. Chart |
1 Month NIVALIS THERAPEUTICS, INC. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions